Agentic AI is already handling invoice processing, site feasibility, patient sourcing, and financial workflow automation in clinical development. But the organizations positioned to capture lasting value from these tools are the ones willing to redesign accountability structures, financial workflows, and operating models before layering new technology on top of them.
The industry has a long track record of buying new tools without changing the processes underneath them. The structural gaps that have always limited clinical operations do not disappear when a new technology wave arrives. Here is what agentic AI requires of clinical operations, and why the operating model conversation is more urgent than the technology one.
The administrative backbone problem
Clinical trials run on administrative work: invoices, site contracts, patient records, regulatory documents. Agentic AI can absorb much of this load. But absorbing work is not the same as improving how that work is governed. If an AI agent processes invoices faster while the underlying approval chain, cost coding, and reconciliation rules remain fragmented across systems, the bottleneck simply moves elsewhere.
Operations leaders should treat agentic AI as a forcing function. The question is not "which tasks can we automate?" but "who owns the outcome when a machine does the task?" That question has no technology answer. It requires decisions about roles, sign-offs, and escalation paths.
Redesigning accountability before deployment
Organizations that deploy agentic AI without first clarifying accountability will likely replicate existing dysfunction at higher speed. An AI agent that triages site feasibility queries still needs a human owner for disputed cases. An AI that flags invoice discrepancies still needs a defined process for resolving them when the vendor disagrees.
For operations teams, this means mapping current workflows before selecting tools. The exercise is not glamorous, but it determines whether agentic AI reduces headcount pressure or simply adds another layer of software to manage.
Financial workflows as the first test case
Invoice processing and financial workflow automation are among the earliest agentic AI deployments in clinical operations. These are high-volume, rules-heavy processes with clear inputs and outputs, which makes them a natural starting point. But they also expose the operating model gaps quickly: inconsistent cost categories across studies, decentralized approval thresholds, and reconciliation steps that rely on institutional memory.
Teams that standardize these workflows before automating them will see measurable returns. Teams that automate first and standardize later will spend months untangling exceptions the AI cannot resolve.
Why this matters for operations professionals
Operations leaders in clinical development should budget time for process redesign before approving agentic AI pilots. The tools are ready; the accountability structures mostly are not. Start with a single workflow, document who owns each decision point, and only then introduce automation. The organizations that do this will extract value from agentic AI. The ones that skip it will buy faster versions of the same broken processes.
Your membership also unlocks:
